Purification and inhibitor screening of human nitric oxide synthase isozymes.
Garvey
E P
EP
Division of Biochemistry, Glaxo Wellcome, Inc., Research Triangle Park,North Carolina 27709, USA.
Furfine
E S
ES
Sherman
P A
PA
D000230:Adenocarcinoma; D001120:Arginine / Q000378:metabolism; D001921:Brain / Q000201:enzymology*; D002250:Carbon Radioisotopes; D002460:Cell Line; D002846:Chromatography, Affinity / Q000379:methods; D002850:Chromatography, Gel / Q000379:methods; D015179:Colorectal Neoplasms; D016207:Cytokines / Q000494:pharmacology; D004591:Electrophoresis, Polyacrylamide Gel; D004730:Endothelium, Vascular / Q000201:enzymology*; D004790:Enzyme Induction / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007202:Indicators and Reagents; D007527:Isoenzymes / Q000032:analysis / Q000037:antagonists & inhibitors / Q000302:isolation & purification; D007700:Kinetics; D009474:Neurons / Q000201:enzymology*; D019001:Nitric Oxide Synthase / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000302:isolation & purification*; D010920:Placenta / Q000201:enzymology*; D011247:Pregnancy; D011865:Radioisotope Dilution Technique
D002250:Carbon Radioisotopes; D016207:Cytokines; D004791:Enzyme Inhibitors; D007202:Indicators and Reagents; D007527:Isoenzymes; D001120:Arginine; D019001:Nitric Oxide Synthase